Anikie Mathoma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anikie Mathoma has a total of 154 co-authors. Here are the top co-authors by number of shared publications:
- Benn Sartorius
The University of Queensland
11 shared publications - Saajida Mahomed
College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
11 shared publications - Andrew F. Auld
Centers for Disease Control and Prevention, Lilongwe, Malawi
10 shared publications - Tefera Agizew
Centers for Disease Control and Prevention, Gaborone, Botswana
7 shared publications Rosanna Boyd
Affiliation Division of TB Elimination, Centers for Disease Control and Prevention, Gaborone, Botswana
6 shared publicationsAlyssa Finlay
U.S. Centers for Disease Control and Prevention (CDC), Gaborone, Botswana
5 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S4 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Mortality Ratios (ASMRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S4 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Mortality Ratios (ASMRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S5 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Mortality Ratios (SMRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S5 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Mortality Ratios (SMRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S3 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Incidence Ratios (SIRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S3 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Within District Standardized Incidence Ratios (SIRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Incidence Rates (ASIRs).
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Crude & Age Standardized Incidence Rates (ASIRs).
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Data from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background:Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion.Methods:We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer.Results:We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma.Conclusions:The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment.Impact:Our results will contribute to the National Cancer Control Plan development.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessData from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background:Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion.Methods:We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer.Results:We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma.Conclusions:The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment.Impact:Our results will contribute to the National Cancer Control Plan development.
- Open Access
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Table S6 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Multivariable imputed ASIR and ASMR.
- 19 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Multivariable imputed ASIR and ASMR.
- Open Access
- 3 April 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (5)
Trends in all-cause mortality after cancer diagnosis among people with and without HIV in Botswana, 1990–2021
Purpose: With a high HIV adult prevalence, the burden of cancer in Botswana has surged over the years, posing a significant threat for people living with HIV (PLWH). While HIV/AIDS-related deaths have declined due to effective antiretroviral therapy (ART), PLWH remain at elevated risk for cancer and related mortality. We aimed to evaluate all-cause mortality after cancer diagnosis among people with and without HIV in Botswana. Methods: We included adults aged ≥ 18 years who were reported in the national cancer registry between 1990 and 2021. The crude, age-standardized mortality (ASMR) rates per 100,000 and standardized mortality ratios (SMRs) were calculated. We determined time trends using generalized linear regression, assuming a Poisson distribution. Results: Over 30 years, 27,726 cancer cases and 9,609 deaths were reported. Of all the deaths, 4,548 (47.3%) were among PLWH, 1,183 (12.3%) among people without HIV, and 3,878 (40.4%) among people with unknown HIV status. Compared with people without HIV, the ASMRs for PLWH were higher and increased significantly from 1990 to 2021 (from 12.5 to 297.9 per 100,000, respectively; p-trend < 0.001) versus people without HIV (from 0.4 to 7.3 per 100,000, respectively; p-trend = 0.006). Further, mortality rates rose among PLWH who had AIDS-defining cancers (ADCs), non-AIDS-defining cancers (NADCs), breast and cervical cancers ( p-trend < 0.001). Although the SMRs for all ADCs and most NADCs sub-types declined after ART roll-out, in the late post-ART period, these were in excess among PLWH. Conclusion: Increasing trends and excess mortality among PLWH with cancer suggest a greater need for targeted screening strategies, and the provision of access to timely HIV and cancer treatment.
- 3 April 2026
- Published by Springer Nature in Cancer Causes & Control
- Vol. 37 (5)
Open AccessTrends in all-cause mortality after cancer diagnosis among people with and without HIV in Botswana, 1990–2021
Purpose: With a high HIV adult prevalence, the burden of cancer in Botswana has surged over the years, posing a significant threat for people living with HIV (PLWH). While HIV/AIDS-related deaths have declined due to effective antiretroviral therapy (ART), PLWH remain at elevated risk for cancer and related mortality. We aimed to evaluate all-cause mortality after cancer diagnosis among people with and without HIV in Botswana. Methods: We included adults aged ≥ 18 years who were reported in the national cancer registry between 1990 and 2021. The crude, age-standardized mortality (ASMR) rates per 100,000 and standardized mortality ratios (SMRs) were calculated. We determined time trends using generalized linear regression, assuming a Poisson distribution. Results: Over 30 years, 27,726 cancer cases and 9,609 deaths were reported. Of all the deaths, 4,548 (47.3%) were among PLWH, 1,183 (12.3%) among people without HIV, and 3,878 (40.4%) among people with unknown HIV status. Compared with people without HIV, the ASMRs for PLWH were higher and increased significantly from 1990 to 2021 (from 12.5 to 297.9 per 100,000, respectively; p-trend < 0.001) versus people without HIV (from 0.4 to 7.3 per 100,000, respectively; p-trend = 0.006). Further, mortality rates rose among PLWH who had AIDS-defining cancers (ADCs), non-AIDS-defining cancers (NADCs), breast and cervical cancers ( p-trend < 0.001). Although the SMRs for all ADCs and most NADCs sub-types declined after ART roll-out, in the late post-ART period, these were in excess among PLWH. Conclusion: Increasing trends and excess mortality among PLWH with cancer suggest a greater need for targeted screening strategies, and the provision of access to timely HIV and cancer treatment.
- 24 March 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (6) , 921-933
Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background: Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion. Methods: We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer. Results: We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma. Conclusions: The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment. Impact: Our results will contribute to the National Cancer Control Plan development.
- 24 March 2026
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 35 (6) , 921-933
Spatiotemporal Patterns of AIDS-Defining and Non–AIDS-Defining Cancers before and after Antiretroviral Therapy Rollout in Botswana, 1990 to 2021
Background: Human immunodeficiency virus (HIV) and cancer comorbidity in Botswana is high. We sought to explore the distribution of acquired immunodeficiency syndrome (AIDS)–defining cancers (ADC) and non-ADCs (NADC) among people living with HIV (PLHIV) and without HIV during antiretroviral therapy (ART) expansion. Methods: We included adults ≥18 years of age reported in Botswana National Cancer Registry (BNCR) between 1990 and 2021. We computed crude, age-standardized incidence rates (ASIR) and age-standardized mortality rates (ASMR) per 100,000 and standardized incidence ratios (SIR) and standardized mortality ratios (SMR) of cancers. We used Bayesian spatial modeling and calculated the relative risk (RR) of cancer. Results: We reported 27,726 cases of cancer. Of these, 13,737 (49.5%) were among PLHIV, 3,505 (12.6%) among those without HIV, and 9,609 (34.7%) had died from all causes. During ART expansion, the ASIRs and ASMRs of all cancers, ADCs, and NADCs increased significantly in all districts, especially North-East and South-East in 2002 to 2007 and 2008 to 2012 and Central District during 2016 to 2021. The SIRs and SMRs declined during the study period in several districts. Most of the districts experienced high RR >1.0 of cancer during the period of 2016 to 2021. Compared with those without HIV, PLHIV had higher incidences of ADCs, NADCs, and subtypes including cervical cancer and Kaposi sarcoma. Conclusions: The overall high cancer risk in several districts, the high burden in more urbanized and populous districts, and increased incidences and all-cause mortality among PLHIV in Botswana highlight the urgent need for improved access to timely cancer screening, diagnosis, and treatment. Impact: Our results will contribute to the National Cancer Control Plan development.
- Open Access
Trends in Cancer Incidence and Associated Risk Factors in People Living with and Without HIV in Botswana: A Population-Based Cancer Registry Data Analysis from 1990 to 2021
Background: With a high human immunodeficiency virus (HIV) adult prevalence, people living with HIV (PLHIV) in Botswana continue to experience a high burden of comorbid HIV and cancer. We sought to investigate the trends of acquired immunodeficiency syndrome (AIDS) defining cancers (ADCs), non-AIDS defining cancers (NADCs), and associated risk factors in PLHIV compared with those without HIV. Methods: We analyzed data from adults aged ≥18 years reported in Botswana National Cancer Registry and National Data Warehouse. The crude, age-standardized incidence rate (ASIR), standardized incidence ratios (SIRs) of cancers and time trends were computed. Risk factors were determined using the Cox-regression model. Results: Over a 30-year period, 27,726 cases of cancer were documented. Of these, 13,737 (49.5%) were PLHIV and 3505 (12.6%) were people without HIV and 10,484 (37.8%) had an unknown HIV status. Compared to the HIV-uninfected, the PLHIV had higher and increasing trends in the cancer incidence overall during the study period (from 44.2 to 1047.6 per 100,000; p-trend < 0.001) versus (from 1.4 to 27.2 per 100,000; p-trend < 0.001). The ASIRs also increased in PLHIV for overall ADCs, NADCs and other sub-types like cervical, lung, breast, and conjunctiva cancers (p-trend < 0.001). Further, PLHIV had elevated SIRs for cervical cancer, Kaposi sarcoma in males and some NADCs. The most common risk factors were HIV infection and female sex for ADCs incidence and advanced age and being HIV-uninfected for NADCs incidence. Conclusions: Increasing trends of ADCs and NADCs during ART expansion were observed among PLHIV compared to those without HIV highlighting a greater need for targeted effective prevention and screening strategies including the provision of access to timely HIV and cancer treatment.
Open AccessTrends in Cancer Incidence and Associated Risk Factors in People Living with and Without HIV in Botswana: A Population-Based Cancer Registry Data Analysis from 1990 to 2021
Background: With a high human immunodeficiency virus (HIV) adult prevalence, people living with HIV (PLHIV) in Botswana continue to experience a high burden of comorbid HIV and cancer. We sought to investigate the trends of acquired immunodeficiency syndrome (AIDS) defining cancers (ADCs), non-AIDS defining cancers (NADCs), and associated risk factors in PLHIV compared with those without HIV. Methods: We analyzed data from adults aged ≥18 years reported in Botswana National Cancer Registry and National Data Warehouse. The crude, age-standardized incidence rate (ASIR), standardized incidence ratios (SIRs) of cancers and time trends were computed. Risk factors were determined using the Cox-regression model. Results: Over a 30-year period, 27,726 cases of cancer were documented. Of these, 13,737 (49.5%) were PLHIV and 3505 (12.6%) were people without HIV and 10,484 (37.8%) had an unknown HIV status. Compared to the HIV-uninfected, the PLHIV had higher and increasing trends in the cancer incidence overall during the study period (from 44.2 to 1047.6 per 100,000; p-trend < 0.001) versus (from 1.4 to 27.2 per 100,000; p-trend < 0.001). The ASIRs also increased in PLHIV for overall ADCs, NADCs and other sub-types like cervical, lung, breast, and conjunctiva cancers (p-trend < 0.001). Further, PLHIV had elevated SIRs for cervical cancer, Kaposi sarcoma in males and some NADCs. The most common risk factors were HIV infection and female sex for ADCs incidence and advanced age and being HIV-uninfected for NADCs incidence. Conclusions: Increasing trends of ADCs and NADCs during ART expansion were observed among PLHIV compared to those without HIV highlighting a greater need for targeted effective prevention and screening strategies including the provision of access to timely HIV and cancer treatment.